Eculizumab Injection

Phase 3

Phase 3

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Paroxysmal Nocturnal Haemoglobinuria (PNH)

Drug Information

Target Indication

Paroxysmal Nocturnal Haemoglobinuria (PNH)

Clinical Trial

Last updated: 2/12/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

SAIC

Science Applications International Corp

Related Pipeline

Delayed Onset Muscle Soreness, DOMS

Dry Eye

Acute Ankle Sprain

Paroxysmal Nocturnal Hemoglobinuria

Infection, Respiratory Tract